Structure, Function, and Activity of Small Molecule and Peptide Inhibitors of Protein Arginine Methyltransferase 1
Protein arginine N-methyltransferases (PRMT) are a family of S-adenosyl-l-methionine (SAM)-dependent enzymes that transfer methyl-groups to the ω-N of arginyl residues in proteins. PRMTs are involved in regulating gene expression, RNA splicing, and other activities. PRMT1 is responsible for most cel...
Gespeichert in:
Veröffentlicht in: | Journal of medicinal chemistry 2024-09, Vol.67 (18), p.15931-15946 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 15946 |
---|---|
container_issue | 18 |
container_start_page | 15931 |
container_title | Journal of medicinal chemistry |
container_volume | 67 |
creator | Hendrickson-Rebizant, Thordur Sudhakar, Sadhana R. N. Rowley, Michael J. Frankel, Adam Davie, James R. Lakowski, Ted M. |
description | Protein arginine N-methyltransferases (PRMT) are a family of S-adenosyl-l-methionine (SAM)-dependent enzymes that transfer methyl-groups to the ω-N of arginyl residues in proteins. PRMTs are involved in regulating gene expression, RNA splicing, and other activities. PRMT1 is responsible for most cellular arginine methylation, and its dysregulation is involved in many cancers. Accordingly, many groups have targeted PRMT1 using small molecules and peptide inhibitors. In this Perspective, we discuss the structure and function of selected peptide and small molecule inhibitors of PRMT1. We examine inhibitors that target the substrate arginyl peptide, SAM, or both binding sites, and the type of inhibition that results. Small molecules, and peptides that are bisubstrate, and/or PRMT transition state mimic inhibitors as well as inhibitors that alkylate PRMTs will be discussed. We define a structure–activity relationship for the aromatic/heteroaromatic N-methylethylenediamine inhibitors of PRMT1 and review current progress of PRMT1 inhibitors in clinical trials. |
doi_str_mv | 10.1021/acs.jmedchem.4c00490 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11440505</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3102470738</sourcerecordid><originalsourceid>FETCH-LOGICAL-a329t-96c7cd2690573e117d75ab31dfe2b248af5deb12435f8eb565dcde00319bf9f3</originalsourceid><addsrcrecordid>eNp9kU9PGzEQxS3UClLab1BVPvbAhvG_bPZURai0SKAiwd3yemeJkddObS9Svj0bElB74TSW5r034_kR8pXBnAFn58bm-eOAnV3jMJcWQDZwRGZMcajkEuQHMgPgvOILLk7Ip5wfAUAwLo7JiWi4AinkjKS7kkZbxoRn9HIMtrgYzqgJHV1N7ydXtjT29G4w3tOb6NGOHl_at7gprkN6FdaudSWmvBPepljQBbpKDy64gPQGy3rrSzIh95hMRso-k4-98Rm_HOopub_8eX_xu7r-8-vqYnVdGcGbUjULW9uOLxpQtUDG6q5WphWs65G3XC5NrzpsGZdC9Uts1UJ1tsPdF5u2b3pxSn7sYzdjuzsThmkLrzfJDSZtdTRO_98Jbq0f4pNmTEpQoKaE74eEFP-OmIseXLbovQkYx6zFxEHWUIvlJJV7qU0x54T92xwGeodLT7j0Ky59wDXZvv2745vplc8kgL3gxR7HFKaLvZ_5DKBDpzg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3102470738</pqid></control><display><type>article</type><title>Structure, Function, and Activity of Small Molecule and Peptide Inhibitors of Protein Arginine Methyltransferase 1</title><source>ACS Publications</source><creator>Hendrickson-Rebizant, Thordur ; Sudhakar, Sadhana R. N. ; Rowley, Michael J. ; Frankel, Adam ; Davie, James R. ; Lakowski, Ted M.</creator><creatorcontrib>Hendrickson-Rebizant, Thordur ; Sudhakar, Sadhana R. N. ; Rowley, Michael J. ; Frankel, Adam ; Davie, James R. ; Lakowski, Ted M.</creatorcontrib><description>Protein arginine N-methyltransferases (PRMT) are a family of S-adenosyl-l-methionine (SAM)-dependent enzymes that transfer methyl-groups to the ω-N of arginyl residues in proteins. PRMTs are involved in regulating gene expression, RNA splicing, and other activities. PRMT1 is responsible for most cellular arginine methylation, and its dysregulation is involved in many cancers. Accordingly, many groups have targeted PRMT1 using small molecules and peptide inhibitors. In this Perspective, we discuss the structure and function of selected peptide and small molecule inhibitors of PRMT1. We examine inhibitors that target the substrate arginyl peptide, SAM, or both binding sites, and the type of inhibition that results. Small molecules, and peptides that are bisubstrate, and/or PRMT transition state mimic inhibitors as well as inhibitors that alkylate PRMTs will be discussed. We define a structure–activity relationship for the aromatic/heteroaromatic N-methylethylenediamine inhibitors of PRMT1 and review current progress of PRMT1 inhibitors in clinical trials.</description><identifier>ISSN: 0022-2623</identifier><identifier>ISSN: 1520-4804</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/acs.jmedchem.4c00490</identifier><identifier>PMID: 39250434</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><ispartof>Journal of medicinal chemistry, 2024-09, Vol.67 (18), p.15931-15946</ispartof><rights>2024 The Authors. Published by American Chemical Society</rights><rights>2024 The Authors. Published by American Chemical Society 2024 The Authors</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-a329t-96c7cd2690573e117d75ab31dfe2b248af5deb12435f8eb565dcde00319bf9f3</cites><orcidid>0009-0000-8709-5599 ; 0009-0005-8030-3961 ; 0000-0002-0420-6888 ; 0009-0000-8965-7786 ; 0000-0002-6625-6717</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.4c00490$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/acs.jmedchem.4c00490$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>230,315,781,785,886,2766,27081,27929,27930,56743,56793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39250434$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hendrickson-Rebizant, Thordur</creatorcontrib><creatorcontrib>Sudhakar, Sadhana R. N.</creatorcontrib><creatorcontrib>Rowley, Michael J.</creatorcontrib><creatorcontrib>Frankel, Adam</creatorcontrib><creatorcontrib>Davie, James R.</creatorcontrib><creatorcontrib>Lakowski, Ted M.</creatorcontrib><title>Structure, Function, and Activity of Small Molecule and Peptide Inhibitors of Protein Arginine Methyltransferase 1</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>Protein arginine N-methyltransferases (PRMT) are a family of S-adenosyl-l-methionine (SAM)-dependent enzymes that transfer methyl-groups to the ω-N of arginyl residues in proteins. PRMTs are involved in regulating gene expression, RNA splicing, and other activities. PRMT1 is responsible for most cellular arginine methylation, and its dysregulation is involved in many cancers. Accordingly, many groups have targeted PRMT1 using small molecules and peptide inhibitors. In this Perspective, we discuss the structure and function of selected peptide and small molecule inhibitors of PRMT1. We examine inhibitors that target the substrate arginyl peptide, SAM, or both binding sites, and the type of inhibition that results. Small molecules, and peptides that are bisubstrate, and/or PRMT transition state mimic inhibitors as well as inhibitors that alkylate PRMTs will be discussed. We define a structure–activity relationship for the aromatic/heteroaromatic N-methylethylenediamine inhibitors of PRMT1 and review current progress of PRMT1 inhibitors in clinical trials.</description><issn>0022-2623</issn><issn>1520-4804</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kU9PGzEQxS3UClLab1BVPvbAhvG_bPZURai0SKAiwd3yemeJkddObS9Svj0bElB74TSW5r034_kR8pXBnAFn58bm-eOAnV3jMJcWQDZwRGZMcajkEuQHMgPgvOILLk7Ip5wfAUAwLo7JiWi4AinkjKS7kkZbxoRn9HIMtrgYzqgJHV1N7ydXtjT29G4w3tOb6NGOHl_at7gprkN6FdaudSWmvBPepljQBbpKDy64gPQGy3rrSzIh95hMRso-k4-98Rm_HOopub_8eX_xu7r-8-vqYnVdGcGbUjULW9uOLxpQtUDG6q5WphWs65G3XC5NrzpsGZdC9Uts1UJ1tsPdF5u2b3pxSn7sYzdjuzsThmkLrzfJDSZtdTRO_98Jbq0f4pNmTEpQoKaE74eEFP-OmIseXLbovQkYx6zFxEHWUIvlJJV7qU0x54T92xwGeodLT7j0Ky59wDXZvv2745vplc8kgL3gxR7HFKaLvZ_5DKBDpzg</recordid><startdate>20240926</startdate><enddate>20240926</enddate><creator>Hendrickson-Rebizant, Thordur</creator><creator>Sudhakar, Sadhana R. N.</creator><creator>Rowley, Michael J.</creator><creator>Frankel, Adam</creator><creator>Davie, James R.</creator><creator>Lakowski, Ted M.</creator><general>American Chemical Society</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0009-0000-8709-5599</orcidid><orcidid>https://orcid.org/0009-0005-8030-3961</orcidid><orcidid>https://orcid.org/0000-0002-0420-6888</orcidid><orcidid>https://orcid.org/0009-0000-8965-7786</orcidid><orcidid>https://orcid.org/0000-0002-6625-6717</orcidid></search><sort><creationdate>20240926</creationdate><title>Structure, Function, and Activity of Small Molecule and Peptide Inhibitors of Protein Arginine Methyltransferase 1</title><author>Hendrickson-Rebizant, Thordur ; Sudhakar, Sadhana R. N. ; Rowley, Michael J. ; Frankel, Adam ; Davie, James R. ; Lakowski, Ted M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a329t-96c7cd2690573e117d75ab31dfe2b248af5deb12435f8eb565dcde00319bf9f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hendrickson-Rebizant, Thordur</creatorcontrib><creatorcontrib>Sudhakar, Sadhana R. N.</creatorcontrib><creatorcontrib>Rowley, Michael J.</creatorcontrib><creatorcontrib>Frankel, Adam</creatorcontrib><creatorcontrib>Davie, James R.</creatorcontrib><creatorcontrib>Lakowski, Ted M.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hendrickson-Rebizant, Thordur</au><au>Sudhakar, Sadhana R. N.</au><au>Rowley, Michael J.</au><au>Frankel, Adam</au><au>Davie, James R.</au><au>Lakowski, Ted M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Structure, Function, and Activity of Small Molecule and Peptide Inhibitors of Protein Arginine Methyltransferase 1</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>2024-09-26</date><risdate>2024</risdate><volume>67</volume><issue>18</issue><spage>15931</spage><epage>15946</epage><pages>15931-15946</pages><issn>0022-2623</issn><issn>1520-4804</issn><eissn>1520-4804</eissn><abstract>Protein arginine N-methyltransferases (PRMT) are a family of S-adenosyl-l-methionine (SAM)-dependent enzymes that transfer methyl-groups to the ω-N of arginyl residues in proteins. PRMTs are involved in regulating gene expression, RNA splicing, and other activities. PRMT1 is responsible for most cellular arginine methylation, and its dysregulation is involved in many cancers. Accordingly, many groups have targeted PRMT1 using small molecules and peptide inhibitors. In this Perspective, we discuss the structure and function of selected peptide and small molecule inhibitors of PRMT1. We examine inhibitors that target the substrate arginyl peptide, SAM, or both binding sites, and the type of inhibition that results. Small molecules, and peptides that are bisubstrate, and/or PRMT transition state mimic inhibitors as well as inhibitors that alkylate PRMTs will be discussed. We define a structure–activity relationship for the aromatic/heteroaromatic N-methylethylenediamine inhibitors of PRMT1 and review current progress of PRMT1 inhibitors in clinical trials.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>39250434</pmid><doi>10.1021/acs.jmedchem.4c00490</doi><tpages>16</tpages><orcidid>https://orcid.org/0009-0000-8709-5599</orcidid><orcidid>https://orcid.org/0009-0005-8030-3961</orcidid><orcidid>https://orcid.org/0000-0002-0420-6888</orcidid><orcidid>https://orcid.org/0009-0000-8965-7786</orcidid><orcidid>https://orcid.org/0000-0002-6625-6717</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-2623 |
ispartof | Journal of medicinal chemistry, 2024-09, Vol.67 (18), p.15931-15946 |
issn | 0022-2623 1520-4804 1520-4804 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11440505 |
source | ACS Publications |
title | Structure, Function, and Activity of Small Molecule and Peptide Inhibitors of Protein Arginine Methyltransferase 1 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-16T02%3A45%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Structure,%20Function,%20and%20Activity%20of%20Small%20Molecule%20and%20Peptide%20Inhibitors%20of%20Protein%20Arginine%20Methyltransferase%201&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Hendrickson-Rebizant,%20Thordur&rft.date=2024-09-26&rft.volume=67&rft.issue=18&rft.spage=15931&rft.epage=15946&rft.pages=15931-15946&rft.issn=0022-2623&rft.eissn=1520-4804&rft_id=info:doi/10.1021/acs.jmedchem.4c00490&rft_dat=%3Cproquest_pubme%3E3102470738%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3102470738&rft_id=info:pmid/39250434&rfr_iscdi=true |